Tesshi Yamada

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 11, 2022
Structural Insight into TNIK Inhibition.

Mutsuko Kukimoto-Niino, Mikako Shirouzu, Tesshi Yamada

|Jul 24, 2021
Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment.

Yuichi Nagakawa, Naoya Nakagawa, Chie Takishita

|Nov 27, 2020
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846.

Teppei Sugano, Mari Masuda, Fumitaka Takeshita

|Feb 29, 2020
Quantification of Biomarker Proteins Using Reverse-Phase Protein Arrays.

Tesshi Yamada

|Jun 17, 2017
Signaling pathway profiling using reverse-phase protein array and its clinical applications.

Mari Masuda, Tesshi Yamada

|Feb 17, 2017
Emergence of TNIK inhibitors in cancer therapeutics.

Tesshi Yamada, Mari Masuda

Pageof 1

Frequent Collaborators

1 joint publications

Mari Masuda

1 joint publications

Noriko Motoi

1 joint publications

Yuichi Nagakawa

1 joint publications

Nobuhiko Nakagawa